A Comprehensive Guide to Immunotherapy Drugs
This section of our website provides comprehensive information on immunotherapy treatments. One page describes each of the general types of immunotherapies available to cancer patients—from antibody drug conjugates (ADCs) to vaccines—and how they work. A second page lists all immunotherapy drugs approved for each tumor type—a clear and concise summary based on tumor classification.
The rest of the pages in this section are devoted to immunotherapy drugs currently approved by the FDA for cancer treatment—one page per drug. In addition to a thorough description of each drug, we also provide a comprehensive Provider Toolkit, which includes detailed information on
- Drug Dosing and Administration
- Notable Toxicities and Management of irAEs (Immune-Related Adverse Effects)
- Clinical Pearls and Best Practices
- Patient and Healthcare Provider Educational Resources
- Q&A Sections to Address Common Concerns
These toolkits are designed to be easily accessible, downloadable, and printable, ensuring that you have the resources you need, whenever you need them.
Some drug pages have further resources, including Patient Action Plans and Care Step Pathways.
Our Goal is to Help You Help Your Patients
As a whole, this section is designed to give you a deeper understanding of the different types of immunotherapies available. Whether you’re a community-based practitioner or an oncologist at a research institution, this section is designed to help you ensure the best outcomes for your patients.
This section will be continuously updated as new immunotherapies are approved by the FDA and as we create more resources for previously approved drugs. Count on AIM with
Immunotherapy to reflect the latest advancements in treatment and provide you with the most current information and resources.
We hope this section serves as a valuable resource to aid your clinical practice and ultimately improve the lives of the patients for whom you care.